Efficacy and Safety of Infliximab Biosimilar Remsima in Psoriasis
Condition(s):PsoriasisLast Updated:September 21, 2023Completed
Hide Studies Not Open or Pending
Condition(s):PsoriasisLast Updated:September 21, 2023Completed
Condition(s):PsoriasisLast Updated:September 13, 2023Completed
Condition(s):Young Healthy PatientsLast Updated:September 8, 2023Completed
Condition(s):Orthopaedic DisordersLast Updated:August 18, 2020Completed
Condition(s):Adolescent Idiopathic ScoliosisLast Updated:November 22, 2019Completed
Condition(s):Minimally Invasive Surgical Procedures; Disk, HerniatedLast Updated:October 31, 2019Completed
Condition(s):Cerebral PalsyLast Updated:February 15, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.